A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target?
Machteld Sillen, Paul J. Declerck · International Journal of Molecular Sciences · 2021 · Review
Full textCC BY
Cancer Research
Filters2 filters applied
Status
Year
Readable here
Study type
Licence
RNA-induced liquid phase separation of SARS-CoV-2 nucleocapsid protein facilitates NF-κB hyper-activation and inflammation
Yaoxing Wu, Ling Ma, Sihui Cai et al. · Signal Transduction and Targeted Therapy · 2021
Full textCC BY
Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer
Jones Gyamfi, Joo Hye Yeo, Doru Kwon et al. · npj Breast Cancer · 2021
Full textCC BY
Advanced Approaches to Breast Cancer Classification and Diagnosis
M. Zubair, S. Wang, N. Ali · Frontiers in Pharmacology · 2021 · Review
Full textCC BY
The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis
Xiaoqing Luo, Enze Zheng, Li Wei et al. · Cell Death & Disease · 2021
Full textCC BY
Tumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter
Tord Hompland, Christina Sæten Fjeldbo, Heidi Lyng · Cancers · 2021 · Review
Full textCC BY
TAK1-TABs Complex: A Central Signalosome in Inflammatory Responses
Yan-Ran Xu, Cao-Qi Lei · Frontiers in Immunology · 2021 · Review
Full textCC BY
Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond
Shing Yau Tam, Vincent W. C. Wu, Helen K. W. Law · Frontiers in Oncology · 2020 · Review
Full textCC BY
Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications
Qinyao Wei, Yun Qian, Jun Yu et al. · Oncogene · 2020 · Review
Full textCC BY
DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types
Vera Constâncio, Sandra P. Nunes, Rui Henrique et al. · Cells · 2020 · Review
Full textCC BY
Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy
Shumei Kato, Ki Hwan Kim, Hyo Jeong Lim et al. · Nature Communications · 2020
Full textCC BY
miRNA Targets: From Prediction Tools to Experimental Validation
Giulia Riolo, Silvia Cantara, Carlotta Marzocchi et al. · Methods and Protocols · 2020 · Review
Full textCC BY
LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer
Qianfeng Shi, Yudong Li, Shunying Li et al. · Nature Communications · 2020
Full textCC BY
The Pervasive Role of the miR-181 Family in Development, Neurodegeneration, and Cancer
Alessia Indrieri, Sabrina Carrella, Pietro Carotenuto et al. · International Journal of Molecular Sciences · 2020 · Review
Full textCC BY
Warburg and Beyond: The Power of Mitochondrial Metabolism to Collaborate or Replace Fermentative Glycolysis in Cancer
Shamir Cassim, Milica Vučetić, Maša Ždralević et al. · Cancers · 2020 · Review
Full textCC BY
Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies
Zhefang Wang, Fanyu Liu, Ningbo Fan et al. · Frontiers in Oncology · 2020 · Review
Full textCC BY
Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis
Kulsoom Zahra, Tulika Dey, Ashish et al. · Frontiers in Oncology · 2020 · Review
Full textCC BY
LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes
Cefan Zhou, Changhua Yi, Yongxiang Yi et al. · Molecular Cancer · 2020
Full textCC BY
Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells
Huangcan Li, Zhuoying Feng, Ming-Liang He · Theranostics · 2020 · Review
Full textCC BY
MALAT1 Long Non-Coding RNA: Functional Implications
Gayatri Arun, Disha Aggarwal, David L. Spector · Non-Coding RNA · 2020 · Review
Full textCC BY